Design and In Vitro Biological Evaluation of a Novel Organotin(IV) Complex with 1-(4-Carboxyphenyl)-3-ethyl-3-methylpyrrolidine-2,5-dione

Table 1

IC₅₀ (µM) (mean ± SD) of CEMPDH, [Ph₃Sn(CEMPD)], and cisplatin (72 h of action).

Compounds	IC50 (µM)
	HeLa	K562	MDA-MB-453
CEMPDH	>200	>200	>200
[Ph3Sn(CEMPD)]	0.22 ± 0.04	0.53 ± 0.01	0.28 ± 0.03
Cisplatin	6.90 ± 1.71	5.82 ± 0.17	6.73 ± 0.48